Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Gregor Serša

PhD Gregor Serša
no.: 08800 source: ARIS

researcher – active in research organisation
(01) 587 94 34
gsersaat signonko-i.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • German
  • Reading: Functional
  • Writing: Basic
  • Speaking: Functional
  • Italian
  • Reading: Basic
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Keywords
Experimental oncology, radiobiology, drug delivery, electrochemotherapy, vinblastine, bleomicyn, cisplatine
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
2,105.85
A''
85.31
A'
797.78
A1/2
1,121.83
CI10
8,133
CImax
514
h10
43
A1
6.34
A3
5
Data for the last 5 years (citations for the last 10 years) on April 24, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 360  12,644  8,888  24.69 
Scopus 386  15,032  10,853  28.12 
Audiovisual sources
no. Title (with video link) Event Source
1. Development and evaluation of new approaches to cancer treatment    Research programme video presentation 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Jerneja Kos  Bologna doctoral studies  10/1/2017 - 9/30/2022  50592 
2 PhD Katja Uršič Valentinuzzi  Bologna doctoral studies  10/1/2015 - 6/30/2019  38223 
3 PhD Ajda Prevc  Bologna doctoral studies  11/1/2014 - 8/31/2018  37415 
4 PhD Špela Kos  Bologna doctoral studies  10/1/2013 - 3/31/2017  36366 
5 PhD Monika Savarin  Bologna doctoral studies  12/1/2012 - 3/31/2017  35355 
6 PhD Maša Omerzel  Bologna doctoral studies  11/1/2011 - 4/30/2015  34373 
7 PhD Aleš Sedlar  Bologna doctoral studies  10/1/2009 - 3/31/2013  32176 
8 PhD Urška Kamenšek  Uniform doctoral studies  11/1/2006 - 4/30/2010  28387 
9 PhD Suzana Vidic  Uniform doctoral studies  10/1/2004 - 3/31/2009  24444 
10 PhD Alenka Grošel  Doctoral degree  11/1/2000 - 4/30/2005  21329 
11 PhD Simona Kranjc Brezar  Doctoral degree  11/1/1998 - 10/31/2003  19058 
12 PhD Maja Čemažar  Doctoral degree  12/15/1993 - 11/30/1998  14575 
13 PhD Barbara Jezeršek Novaković  Doctoral degree  5/1/1991 - 5/31/1998  12022 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.   Physiology  SI University of Ljubljana, Biotechnical Faculty 1979 
Master's degree    Immunology  SI University of Ljubljana, Faculty of Medicine 1985 
Doctor's degree  Ph. D.   Biomedicine  SI University of Ljubljana, Faculty of Medicine 1988 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position ecris.org.employ_rolegroup Title
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research  9/19/1979    Researcher  Full professor 
Full time employment (20%, RD:0%)  University of Ljubljana, Faculty of Health Sciences  Biomedical Research Group  10/1/2016  Associate professor  Researcher  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,193 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,905 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,833 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,084 
5. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   2023 - 2024  PhD Matej Reberšek  3,469 
6. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2024  PhD Igor Muševič  5,470 
7. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,919 
8. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,050 
9. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,770 
10. BI-US/22-24-026  Biomarkers to aid the efficacy of electrochemotherapy in combination with immunogenic therapy for cancer treatment   2022 - 2024  PhD Gregor Serša  1,511 
11. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   2020 - 2023  PhD Maja Čemažar  3,173 
12. J4-2546  Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours   2020 - 2023  PhD Nataša Tozon  3,556 
13. J3-2529  Role of endothelium in tumor response to radiotherapy   2020 - 2023  PhD Boštjan Markelc  3,338 
14. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   2020 - 2023  PhD Mateja Erdani Kreft  5,132 
15. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,496 
16. J2-9225  Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields   2018 - 2021  PhD Damijan Miklavčič  2,900 
17. N3-0059  Plasma-assisted wound treatment and topical introduction of molecules   2017 - 2020  PhD Uroš Cvelbar  3,038 
18. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   2017 - 2020  PhD Janko Kos  4,553 
19. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2017 - 2020  PhD Maja Čemažar  3,542 
20. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   2016 - 2019  PhD Igor Emri  4,425 
21. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   2016 - 2018  PhD Primož Strojan  4,258 
22. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments   2016 - 2018  PhD Mateja Erdani Kreft  7,081 
23. J1-6730  Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection   2014 - 2017  PhD Metka Filipič  4,044 
24. J1-6744  Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis   2014 - 2017  PhD Tina Kosjek  4,810 
25. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,092 
26. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,739 
27. J3-5505  Electrochemotherapy in treatment of deep seated tumors   2013 - 2016  PhD Gregor Serša  4,269 
28. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2016  PhD Janko Kos  5,950 
29. J3-4211  Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems   2011 - 2014  PhD Gregor Serša  6,456 
30. J1-4044  Apoptotic effects of alkylpyridinium compounds on lung adenocarcinoma cells   2011 - 2014  PhD Tom Turk  6,261 
31. L2-4105  Development and validation of a software for numerical modeling of in vivo electroporation - in silico electroporation   2011 - 2014  PhD Damijan Miklavčič  4,817 
32. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2014  PhD Maja Čemažar  5,848 
33. J1-4131  Synthesis, characterisation and use of novel ruthenium compounds in electrochemotherapy of tumors   2011 - 2014  PhD Iztok Turel  5,936 
34. J2-3639  New lipid model systems for determination of electroporation basic mechanisms   2010 - 2013  PhD Damijan Miklavčič  5,137 
35. J3-2069  Uporaba magnetne nanotehnologije za transfekcijo normalnih in tumorskih celic (Slovene)   2009 - 2012  PhD Gregor Serša  2,786 
36. J3-0485  Antiangiogenic siRNA for the treatment of advanced malignant melanoma   2008 - 2011  PhD Maja Čemažar  2,585 
37. J1-0200  Synthesis of novel ruthenium compounds and their potential use in electrochemotherapy of tumors   2008 - 2011  PhD Iztok Turel  4,373 
38. J3-9580  Development of cell biosensor systems for determination of effects of ionizing radiation and chemical carcinogens   2007 - 2009  PhD Gregor Serša  2,468 
39. M1-0153  Biološka dozimetrija na osnovi magnetno resonančnih metod (Slovene)   2008  PhD Marjeta Šentjurc  6,895 
40. V3-0371  Znanstveno raziskovalni zavodi na področju biomedicinskih znanosti - izsledki biomedicinskih raziskav in učinkovita oblika organiziranosti (Slovene)   2007 - 2008  PhD Bojan Zalar  5,125 
41. J3-7044  Treatment of malignant tumours with electrogene therapy   2005 - 2008  PhD Maja Čemažar  3,351 
42. J3-6443  Metodologija za analizo scientometričnih podatkov v medicini (Slovene)   2004 - 2007  PhD Štefan Adamič  4,335 
43. J3-6260  Vpliv infuzij nizkih odmerkov citostatikov na tumorske celice in pretok krvi v tumorjih (Slovene)   2004 - 2007  PhD Marija Auersperg  4,350 
44. J3-4291  Napovedni pomen proteinov uPA sistema za odgovor na sistemsko zdravljenje in za lokalno ponovitev bolezni pri bolnicah z rakom dojk (Slovene)   2002 - 2005  PhD Tanja Čufer  4,472 
45. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   2002 - 2005  PhD Maja Čemažar  4,834 
46. J3-3501  Creation of tumor vaccines   2002 - 2004  PhD Srdjan Novaković  3,490 
47. L3-3375  Introduction of threedimensional radiotherapy treatment planning in Slovenia   2002 - 2004  PhD Hotimir Lešničar  5,913 
48. J3-3489  New biomedical applications of electroporation   2002 - 2004  PhD Gregor Serša  4,063 
49. J3-3026  Role of cytomorphology, DNA measurements, Ki 67 and apoptosis for planning and predicting the effect of chemotherapy in thyroid cancer   2002 - 2004  PhD Ana Pogačnik  3,436 
50. J3-2165  Napovedni pomen proteinov uPA sistema in katepsinov za prezivetje in odgovor na sistemsko zdravljenje bolnic z rakom dojk (Slovene)   2002  PhD Tanja Čufer  4,536 
51. J3-2049  Uporaba elektroporacij v genski terapiji (Slovene)   2000 - 2002  PhD Maja Čemažar  4,106 
52. J3-7842  Racionalna diagnostika in zdravljenje tumorjev ščitnice (Slovene)   2000 - 2001  PhD Nikola Bešić  2,968 
53. J3-0123  Protitelesa proti proteinu p53 in p53 v serumu bolnikov z malignimi tumorji (Slovene)   1999 - 2001  PhD Zvonimir Rudolf  3,631 
54. J3-7843  Elektrokemoterapija - nov pristop k zdravljenju raka (Slovene)   1996 - 2001  PhD Gregor Serša  4,128 
55. J3-7878  Razvoj avtolognih tumorskih vakcin (Slovene)   1996 - 2001  PhD Srdjan Novaković  5,627 
56. L1-0469  Optimization of MDP and TNF analogues having therapeutic potential   1998 - 2000  PhD Anton Štalc  6,234 
57. J3-8748  Boron Neutron Capture Therapy - Employment of drug delivery systems for increased antitumor effectiveness   1999  PhD Janez Škrk  4,896 
58. J3-8679  Apoptosis and the immune system   1998 - 1999  PhD Vladimir Kotnik  6,504 
59. J3-8746  Prognostic value of uPA, PAI 1 and PAI 2 in solid tumors   1997 - 1999  PhD Tanja Čufer  3,987 
60. L1-7379  Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)   1998  PhD Anton Štalc  6,015 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2024  PhD Gregor Serša  3,948 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,264 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2009 - 2014  PhD Gregor Serša  4,018 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   2004 - 2008  PhD Gregor Serša  3,076 
Confirmation required
Views history
Favourite